Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-023767
Filing Date
2020-09-01
Accepted
2020-09-01 16:30:22
Documents
1
Period of Report
2020-08-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4892
  Complete submission text file 0000899243-20-023767.txt   6462
Mailing Address 11682 EL CAMINO REAL, SUITE 320 SAN DIEGO CA 92130
Business Address
Davis Aaron I. (Reporting) CIK: 0001465914 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38318 | Film No.: 201154767

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 858-200-3830
Odonate Therapeutics, Inc. (Issuer) CIK: 0001717452 (see all company filings)

EIN.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations